Literature DB >> 29516368

Chemokine receptors: Key for molecular imaging of inflammation in atherosclerosis.

Yongjian Liu1, Pamela K Woodard2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29516368      PMCID： PMC6128785          DOI： 10.1007/s12350-018-1248-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  18 in total

Review 1.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 2.  Imaging of atherosclerosis -- can we predict plaque rupture?

Authors:  James H F Rudd; John R Davies; Peter L Weissberg
Journal:  Trends Cardiovasc Med       Date:  2005-01       Impact factor: 6.677

Review 3.  "In vivo" imaging of atherosclerosis.

Authors:  Augusto Gallino; Matthias Stuber; Filippo Crea; Erling Falk; Roberto Corti; John Lekakis; Jürg Schwitter; Paolo Camici; Oliver Gaemperli; Marcello Di Valentino; John Prior; Hector M Garcia-Garcia; Charalambos Vlachopoulos; Francesco Cosentino; Stephan Windecker; Giovanni Pedrazzini; Richard Conti; François Mach; Raffaele De Caterina; Peter Libby
Journal:  Atherosclerosis       Date:  2012-05-08       Impact factor: 5.162

Review 4.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

5.  Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice.

Authors:  Vincent Braunersreuther; Alma Zernecke; Claire Arnaud; Elisa A Liehn; Sabine Steffens; Erdenechimeg Shagdarsuren; Kiril Bidzhekov; Fabienne Burger; Graziano Pelli; Bruno Luckow; François Mach; Christian Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-30       Impact factor: 8.311

Review 6.  Molecular and metabolic imaging of atherosclerosis.

Authors:  John R Davies; James H Rudd; Peter L Weissberg
Journal:  J Nucl Med       Date:  2004-11       Impact factor: 10.057

7.  Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET.

Authors:  Yongjian Liu; Dana Abendschein; Geoffrey E Woodard; Raffaella Rossin; Kyle McCommis; Jie Zheng; Michael J Welch; Pamela K Woodard
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

8.  CC chemokine receptor 5 influences late-stage atherosclerosis.

Authors:  Marlon P Quinones; Hernan G Martinez; Fabio Jimenez; Carlos A Estrada; Molly Dudley; Opal Willmon; Hemant Kulkarni; Robert L Reddick; Gabriel Fernandes; William A Kuziel; Sunil K Ahuja; Seema S Ahuja
Journal:  Atherosclerosis       Date:  2007-04-26       Impact factor: 5.162

9.  PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.

Authors:  Hannah P Luehmann; Eric D Pressly; Lisa Detering; Cynthia Wang; Richard Pierce; Pamela K Woodard; Robert J Gropler; Craig J Hawker; Yongjian Liu
Journal:  J Nucl Med       Date:  2014-03-03       Impact factor: 10.057

Review 10.  Chemokines and their receptors in Atherosclerosis.

Authors:  Emiel P C van der Vorst; Yvonne Döring; Christian Weber
Journal:  J Mol Med (Berl)       Date:  2015-07-15       Impact factor: 4.599
View more
  1 in total

1.  CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography.

Authors:  Lisa Detering; Allison Abdilla; Hannah P Luehmann; Jesse W Williams; Li-Hao Huang; Deborah Sultan; Andrew Elvington; Gyu Seong Heo; Pamela K Woodard; Robert J Gropler; Gwendalyn J Randolph; Craig J Hawker; Yongjian Liu
Journal:  Mol Pharm       Date:  2021-02-16       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.